We are live on ! Find out more
IH

iHuman
IH

8 hedge funds and large institutions have $180K invested in iHuman in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

14% more funds holding

Funds holding: 7 → 8 (+1)

0.04% more ownership

Funds ownership: 0.21% → 0.25% (+0.04%)

2% less capital invested

Capital invested by funds: $184K → $180K (-$3.89K)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$20.3K
2
Credit Agricole
Credit Agricole
France
+$16.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$12.3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.8K
5
UBS Group
UBS Group
Switzerland
+$48

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$26.1K
2
BlackRock
BlackRock
New York
-$546

IH Hedge Fund Activity: Q2 2026 in Review

8 of the 8,329 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q2 2026, worth a combined $180K — down 2.1% from $184K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new IH positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $20.3K. The largest seller was Morgan Stanley, cutting an estimated $26.1K.

  • 8 institutional investors held iHuman (IH) as of Q2 2026, up from 7 in Q1 2026.
  • Funds reported $180K of iHuman stock for Q2 2026, down 2.1% quarter-over-quarter.
  • 2 funds opened new iHuman positions in Q2 2026 and 1 closed out, a net change of +1 holder.
  • The largest iHuman buyer in Q2 2026 was Goldman Sachs, an estimated $20.3K added.
  • The largest iHuman seller in Q2 2026 was Morgan Stanley, an estimated $26.1K sold.

Based on aggregated 13F filings for Q2 2026.